Nevro Corp Current Valuation vs. Profit Margin
| NVRO Stock | USD 4.60 0.02 0.44% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.53 | 0.6822 |
|
|
For Nevro Corp profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Nevro Corp to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Nevro Corp utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Nevro Corp's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Nevro Corp over time as well as its relative position and ranking within its peers.
Nevro |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nevro Corp. If investors know Nevro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nevro Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.87) | Revenue Per Share 11.404 | Quarterly Revenue Growth (0.07) | Return On Assets (0.09) | Return On Equity (0.25) |
The market value of Nevro Corp is measured differently than its book value, which is the value of Nevro that is recorded on the company's balance sheet. Investors also form their own opinion of Nevro Corp's value that differs from its market value or its book value, called intrinsic value, which is Nevro Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nevro Corp's market value can be influenced by many factors that don't directly affect Nevro Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nevro Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nevro Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nevro Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Nevro Corp Profit Margin vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Nevro Corp's current stock value. Our valuation model uses many indicators to compare Nevro Corp value to that of its competitors to determine the firm's financial worth. Nevro Corp is rated below average in current valuation category among its peers. It is rated below average in profit margin category among its peers . At this time, Nevro Corp's Net Loss is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nevro Corp's earnings, one of the primary drivers of an investment's value.Nevro Corp's Earnings Breakdown by Geography
Nevro Current Valuation vs. Competition
Nevro Corp is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is now estimated at about 29.43 Billion. Nevro Corp adds roughly 141.17 Million in current valuation claiming only tiny portion of equities under Health Care industry.
Nevro Profit Margin vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Nevro Corp |
| = | 141.17 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Nevro Corp |
| = | (0.17) % |
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Nevro Profit Margin Comparison
Nevro Corp is currently under evaluation in profit margin category among its peers.
Nevro Corp Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Nevro Corp, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Nevro Corp will eventually generate negative long term returns. The profitability progress is the general direction of Nevro Corp's change in net profit over the period of time. It can combine multiple indicators of Nevro Corp, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -243 K | -255.2 K | |
| Operating Income | -99.3 M | -94.3 M | |
| Income Before Tax | -97.9 M | -93 M | |
| Total Other Income Expense Net | 1.4 M | 1.5 M | |
| Net Loss | -92.2 M | -87.6 M | |
| Income Tax Expense | -5.6 M | -5.4 M | |
| Net Loss | -102.4 M | -97.3 M | |
| Non Operating Income Net Other | 5.2 M | 5.5 M | |
| Net Income Applicable To Common Shares | 2.7 M | 2.8 M | |
| Interest Income | 12.7 M | 13.3 M | |
| Net Interest Income | 6.2 M | 6.5 M | |
| Change To Netincome | 70.5 M | 37.1 M | |
| Net Loss | (2.56) | (2.69) | |
| Income Quality | 0.64 | 1.10 | |
| Net Income Per E B T | 0.94 | 1.09 |
Nevro Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Nevro Corp. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Nevro Corp position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Nevro Corp's important profitability drivers and their relationship over time.
Use Nevro Corp in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Nevro Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nevro Corp will appreciate offsetting losses from the drop in the long position's value.Nevro Corp Pair Trading
Nevro Corp Pair Trading Analysis
The ability to find closely correlated positions to Nevro Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Nevro Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Nevro Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Nevro Corp to buy it.
The correlation of Nevro Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Nevro Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Nevro Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Nevro Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Nevro Corp position
In addition to having Nevro Corp in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Cancer Fighters Thematic Idea Now
Cancer Fighters
Biotech and medical diagnostic companies that work on researching drugs or manufacturing of medical and therapeutics equipment that is directly related to the research, treatment, and detection of cancer or cancer related diseases. The Cancer Fighters theme has 60 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cancer Fighters Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Correlation Analysis. To learn how to invest in Nevro Stock, please use our How to Invest in Nevro Corp guide.You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
To fully project Nevro Corp's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Nevro Corp at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Nevro Corp's income statement, its balance sheet, and the statement of cash flows.